Physician profile
Ryan Demello
NPI 1780410043
$2,582.99
in general payments reported to CMS, 2019-2025
20 companies · $2,378 in 2025
The $2,378 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $205 · 2025: $2,378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,488 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,488.00 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $365.62 | 2025 | Bimzelx |
| Janssen Biotech, INC. | $331.27 | 2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $301.81 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $182.90 | 2024-2025 | |
| Amgen INC. | $169.23 | 2025 | Otezla |
| Integra Lifesciences Corporation | $165.69 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Regeneron Healthcare Solutions, INC. | $156.14 | 2024-2025 | Dupixent |
| Arcutis Biotherapeutics, INC. | $136.51 | 2025 | Zoryve |
| Abbvie INC. | $128.76 | 2024-2025 | |
| Incyte Corporation | $112.18 | 2024-2025 | Opzelura |
| Galderma Laboratories, L.P. | $108.38 | 2025 | Nemluvio |
| Genzyme Corporation | $77.03 | 2024-2025 | |
| Lilly USA, LLC | $60.21 | 2025 | Taltz, Ebglyss |
| Pfizer INC. | $57.13 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $52.70 | 2024-2025 | Sotyktu |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $51.04 | 2025 | Adbry |
| Botanix Sb INC | $41.12 | 2025 | Sofdra |
| Organon LLC | $35.66 | 2025 | |
| Mayne Pharma Commercial LLC | $25.84 | 2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $23.77 | 2025 | Cabtreo, Jublia, Siliq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Demello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.